Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone clinical trial (NCT01605084). Contact the study team or your healthcare provider for specific answers.

Question 2

How do these treatments compare to what I am currently taking?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone clinical trial (NCT01605084). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone clinical trial (NCT01605084). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone clinical trial (NCT01605084). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or procedures would I need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone clinical trial (NCT01605084). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone clinical trial (NCT01605084). Contact the study team or your healthcare provider for specific answers.

What this study is about